カテゴリ： 世界, 医療/バイオ, Market Monitor Global

非侵襲的着床前遺伝子検査のグローバル市場展望 2023年-2029年：着床前遺伝子スクリーニング、着床前遺伝子診断

■ 英語タイトル：Non-invasive Preimplantation Genetic Testing Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC16262）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC16262
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：158
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[非侵襲的着床前遺伝子検査のグローバル市場展望 2023年-2029年：着床前遺伝子スクリーニング、着床前遺伝子診断]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の非侵襲的着床前遺伝子検査市場規模と予測を収録しています。・世界の非侵襲的着床前遺伝子検査市場：売上、2018年-2023年、2024年-2029年
・世界の非侵襲的着床前遺伝子検査市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の非侵襲的着床前遺伝子検査市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「着床前遺伝子スクリーニング」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

非侵襲的着床前遺伝子検査のグローバル主要企業は、Illumina、 Thermo Fisher Scientific、 Agilent、 Revvity、 The Cooper Companies、 Abbott、 TAKARA、 QIAGEN、 Vitrolife、 Oxford Nanopore Technologies、 Yikon Genomics、 Shiva Scientific、 Medicover Genetics、 MedGenome、 Fulgent、 INVICTA GENETICS、 Genea Fertility、 Bioarray、 GeneMind Biosciences、 Unimed Biotechなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、非侵襲的着床前遺伝子検査のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の非侵襲的着床前遺伝子検査市場：タイプ別、2018年-2023年、2024年-2029年
世界の非侵襲的着床前遺伝子検査市場：タイプ別市場シェア、2022年
・着床前遺伝子スクリーニング、着床前遺伝子診断

世界の非侵襲的着床前遺伝子検査市場：用途別、2018年-2023年、2024年-2029年
世界の非侵襲的着床前遺伝子検査市場：用途別市場シェア、2022年
・病院、検査機関、その他

世界の非侵襲的着床前遺伝子検査市場：地域・国別、2018年-2023年、2024年-2029年
世界の非侵襲的着床前遺伝子検査市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における非侵襲的着床前遺伝子検査のグローバル売上、2018年-2023年
・主要企業における非侵襲的着床前遺伝子検査のグローバル売上シェア、2022年
・主要企業における非侵襲的着床前遺伝子検査のグローバル販売量、2018年-2023年
・主要企業における非侵襲的着床前遺伝子検査のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Illumina、 Thermo Fisher Scientific、 Agilent、 Revvity、 The Cooper Companies、 Abbott、 TAKARA、 QIAGEN、 Vitrolife、 Oxford Nanopore Technologies、 Yikon Genomics、 Shiva Scientific、 Medicover Genetics、 MedGenome、 Fulgent、 INVICTA GENETICS、 Genea Fertility、 Bioarray、 GeneMind Biosciences、 Unimed Biotech

*************************************************************

・調査・分析レポートの概要
非侵襲的着床前遺伝子検査市場の定義
市場セグメント
世界の非侵襲的着床前遺伝子検査市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の非侵襲的着床前遺伝子検査市場規模
世界の非侵襲的着床前遺伝子検査市場規模：2022年 VS 2029年
世界の非侵襲的着床前遺伝子検査市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの非侵襲的着床前遺伝子検査の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の非侵襲的着床前遺伝子検査製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：着床前遺伝子スクリーニング、着床前遺伝子診断
非侵襲的着床前遺伝子検査のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、検査機関、その他
非侵襲的着床前遺伝子検査の用途別グローバル売上・予測

・地域別市場分析
地域別非侵襲的着床前遺伝子検査市場規模 2022年と2029年
地域別非侵襲的着床前遺伝子検査売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Illumina、 Thermo Fisher Scientific、 Agilent、 Revvity、 The Cooper Companies、 Abbott、 TAKARA、 QIAGEN、 Vitrolife、 Oxford Nanopore Technologies、 Yikon Genomics、 Shiva Scientific、 Medicover Genetics、 MedGenome、 Fulgent、 INVICTA GENETICS、 Genea Fertility、 Bioarray、 GeneMind Biosciences、 Unimed Biotech
...

This research report provides a comprehensive analysis of the Non-invasive Preimplantation Genetic Testing market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Non-invasive Preimplantation Genetic Testing market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Non-invasive Preimplantation Genetic Testing, challenges faced by the industry, and potential opportunities for market players.
The global Non-invasive Preimplantation Genetic Testing market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Non-invasive Preimplantation Genetic Testing market presents opportunities for various stakeholders, including Hospitals, Diagnostic Laboratories. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Non-invasive Preimplantation Genetic Testing market. Additionally, the growing consumer demand present avenues for market expansion.
The global Non-invasive Preimplantation Genetic Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Non-invasive Preimplantation Genetic Testing market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Non-invasive Preimplantation Genetic Testing market.
Market Overview: The report provides a comprehensive overview of the Non-invasive Preimplantation Genetic Testing market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Non-invasive Preimplantation Genetic Testing market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Non-invasive Preimplantation Genetic Testing market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Non-invasive Preimplantation Genetic Testing market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Non-invasive Preimplantation Genetic Testing market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Non-invasive Preimplantation Genetic Testing market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Non-invasive Preimplantation Genetic Testing market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Non-invasive Preimplantation Genetic Testing, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Non-invasive Preimplantation Genetic Testing market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Non-invasive Preimplantation Genetic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
Market segment by Application
Hospitals
Diagnostic Laboratories
Other
Global Non-invasive Preimplantation Genetic Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Illumina
Thermo Fisher Scientific
Agilent
Revvity
The Cooper Companies
Abbott
TAKARA
QIAGEN
Vitrolife
Oxford Nanopore Technologies
Yikon Genomics
Shiva Scientific
Medicover Genetics
MedGenome
Fulgent
INVICTA GENETICS
Genea Fertility
Bioarray
GeneMind Biosciences
Unimed Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-invasive Preimplantation Genetic Testing, market overview.
Chapter 2: Global Non-invasive Preimplantation Genetic Testing market size in revenue and volume.
Chapter 3: Detailed analysis of Non-invasive Preimplantation Genetic Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-invasive Preimplantation Genetic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non-invasive Preimplantation Genetic Testing capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Non-invasive Preimplantation Genetic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-invasive Preimplantation Genetic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-invasive Preimplantation Genetic Testing Overall Market Size
2.1 Global Non-invasive Preimplantation Genetic Testing Market Size: 2022 VS 2029
2.2 Global Non-invasive Preimplantation Genetic Testing Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Non-invasive Preimplantation Genetic Testing Sales: 2018-2029
3 Company Landscape
3.1 Top Non-invasive Preimplantation Genetic Testing Players in Global Market
3.2 Top Global Non-invasive Preimplantation Genetic Testing Companies Ranked by Revenue
3.3 Global Non-invasive Preimplantation Genetic Testing Revenue by Companies
3.4 Global Non-invasive Preimplantation Genetic Testing Sales by Companies
3.5 Global Non-invasive Preimplantation Genetic Testing Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Non-invasive Preimplantation Genetic Testing Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Non-invasive Preimplantation Genetic Testing Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-invasive Preimplantation Genetic Testing Players in Global Market
3.8.1 List of Global Tier 1 Non-invasive Preimplantation Genetic Testing Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-invasive Preimplantation Genetic Testing Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Non-invasive Preimplantation Genetic Testing Market Size Markets, 2022 & 2029
4.1.2 Preimplantation Genetic Screening
4.1.3 Preimplantation Genetic Diagnosis
4.2 By Type – Global Non-invasive Preimplantation Genetic Testing Revenue & Forecasts
4.2.1 By Type – Global Non-invasive Preimplantation Genetic Testing Revenue, 2018-2023
4.2.2 By Type – Global Non-invasive Preimplantation Genetic Testing Revenue, 2024-2029
4.2.3 By Type – Global Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
4.3 By Type – Global Non-invasive Preimplantation Genetic Testing Sales & Forecasts
4.3.1 By Type – Global Non-invasive Preimplantation Genetic Testing Sales, 2018-2023
4.3.2 By Type – Global Non-invasive Preimplantation Genetic Testing Sales, 2024-2029
4.3.3 By Type – Global Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
4.4 By Type – Global Non-invasive Preimplantation Genetic Testing Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Non-invasive Preimplantation Genetic Testing Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Other
5.2 By Application – Global Non-invasive Preimplantation Genetic Testing Revenue & Forecasts
5.2.1 By Application – Global Non-invasive Preimplantation Genetic Testing Revenue, 2018-2023
5.2.2 By Application – Global Non-invasive Preimplantation Genetic Testing Revenue, 2024-2029
5.2.3 By Application – Global Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
5.3 By Application – Global Non-invasive Preimplantation Genetic Testing Sales & Forecasts
5.3.1 By Application – Global Non-invasive Preimplantation Genetic Testing Sales, 2018-2023
5.3.2 By Application – Global Non-invasive Preimplantation Genetic Testing Sales, 2024-2029
5.3.3 By Application – Global Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
5.4 By Application – Global Non-invasive Preimplantation Genetic Testing Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Non-invasive Preimplantation Genetic Testing Market Size, 2022 & 2029
6.2 By Region – Global Non-invasive Preimplantation Genetic Testing Revenue & Forecasts
6.2.1 By Region – Global Non-invasive Preimplantation Genetic Testing Revenue, 2018-2023
6.2.2 By Region – Global Non-invasive Preimplantation Genetic Testing Revenue, 2024-2029
6.2.3 By Region – Global Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
6.3 By Region – Global Non-invasive Preimplantation Genetic Testing Sales & Forecasts
6.3.1 By Region – Global Non-invasive Preimplantation Genetic Testing Sales, 2018-2023
6.3.2 By Region – Global Non-invasive Preimplantation Genetic Testing Sales, 2024-2029
6.3.3 By Region – Global Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Non-invasive Preimplantation Genetic Testing Revenue, 2018-2029
6.4.2 By Country – North America Non-invasive Preimplantation Genetic Testing Sales, 2018-2029
6.4.3 US Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.4.4 Canada Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.4.5 Mexico Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Non-invasive Preimplantation Genetic Testing Revenue, 2018-2029
6.5.2 By Country – Europe Non-invasive Preimplantation Genetic Testing Sales, 2018-2029
6.5.3 Germany Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.4 France Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.5 U.K. Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.6 Italy Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.7 Russia Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.8 Nordic Countries Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.5.9 Benelux Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Non-invasive Preimplantation Genetic Testing Revenue, 2018-2029
6.6.2 By Region – Asia Non-invasive Preimplantation Genetic Testing Sales, 2018-2029
6.6.3 China Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.6.4 Japan Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.6.5 South Korea Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.6.6 Southeast Asia Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.6.7 India Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Non-invasive Preimplantation Genetic Testing Revenue, 2018-2029
6.7.2 By Country – South America Non-invasive Preimplantation Genetic Testing Sales, 2018-2029
6.7.3 Brazil Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.7.4 Argentina Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales, 2018-2029
6.8.3 Turkey Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.8.4 Israel Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.8.5 Saudi Arabia Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
6.8.6 UAE Non-invasive Preimplantation Genetic Testing Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Illumina
7.1.1 Illumina Company Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.1.4 Illumina Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.1.5 Illumina Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.2.4 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Agilent
7.3.1 Agilent Company Summary
7.3.2 Agilent Business Overview
7.3.3 Agilent Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.3.4 Agilent Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.3.5 Agilent Key News & Latest Developments
7.4 Revvity
7.4.1 Revvity Company Summary
7.4.2 Revvity Business Overview
7.4.3 Revvity Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.4.4 Revvity Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.4.5 Revvity Key News & Latest Developments
7.5 The Cooper Companies
7.5.1 The Cooper Companies Company Summary
7.5.2 The Cooper Companies Business Overview
7.5.3 The Cooper Companies Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.5.4 The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.5.5 The Cooper Companies Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.6.4 Abbott Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 TAKARA
7.7.1 TAKARA Company Summary
7.7.2 TAKARA Business Overview
7.7.3 TAKARA Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.7.4 TAKARA Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.7.5 TAKARA Key News & Latest Developments
7.8 QIAGEN
7.8.1 QIAGEN Company Summary
7.8.2 QIAGEN Business Overview
7.8.3 QIAGEN Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.8.4 QIAGEN Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.8.5 QIAGEN Key News & Latest Developments
7.9 Vitrolife
7.9.1 Vitrolife Company Summary
7.9.2 Vitrolife Business Overview
7.9.3 Vitrolife Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.9.4 Vitrolife Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.9.5 Vitrolife Key News & Latest Developments
7.10 Oxford Nanopore Technologies
7.10.1 Oxford Nanopore Technologies Company Summary
7.10.2 Oxford Nanopore Technologies Business Overview
7.10.3 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.10.4 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.10.5 Oxford Nanopore Technologies Key News & Latest Developments
7.11 Yikon Genomics
7.11.1 Yikon Genomics Company Summary
7.11.2 Yikon Genomics Business Overview
7.11.3 Yikon Genomics Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.11.4 Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.11.5 Yikon Genomics Key News & Latest Developments
7.12 Shiva Scientific
7.12.1 Shiva Scientific Company Summary
7.12.2 Shiva Scientific Business Overview
7.12.3 Shiva Scientific Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.12.4 Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.12.5 Shiva Scientific Key News & Latest Developments
7.13 Medicover Genetics
7.13.1 Medicover Genetics Company Summary
7.13.2 Medicover Genetics Business Overview
7.13.3 Medicover Genetics Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.13.4 Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.13.5 Medicover Genetics Key News & Latest Developments
7.14 MedGenome
7.14.1 MedGenome Company Summary
7.14.2 MedGenome Business Overview
7.14.3 MedGenome Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.14.4 MedGenome Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.14.5 MedGenome Key News & Latest Developments
7.15 Fulgent
7.15.1 Fulgent Company Summary
7.15.2 Fulgent Business Overview
7.15.3 Fulgent Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.15.4 Fulgent Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.15.5 Fulgent Key News & Latest Developments
7.16 INVICTA GENETICS
7.16.1 INVICTA GENETICS Company Summary
7.16.2 INVICTA GENETICS Business Overview
7.16.3 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.16.4 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.16.5 INVICTA GENETICS Key News & Latest Developments
7.17 Genea Fertility
7.17.1 Genea Fertility Company Summary
7.17.2 Genea Fertility Business Overview
7.17.3 Genea Fertility Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.17.4 Genea Fertility Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.17.5 Genea Fertility Key News & Latest Developments
7.18 Bioarray
7.18.1 Bioarray Company Summary
7.18.2 Bioarray Business Overview
7.18.3 Bioarray Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.18.4 Bioarray Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.18.5 Bioarray Key News & Latest Developments
7.19 GeneMind Biosciences
7.19.1 GeneMind Biosciences Company Summary
7.19.2 GeneMind Biosciences Business Overview
7.19.3 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.19.4 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.19.5 GeneMind Biosciences Key News & Latest Developments
7.20 Unimed Biotech
7.20.1 Unimed Biotech Company Summary
7.20.2 Unimed Biotech Business Overview
7.20.3 Unimed Biotech Non-invasive Preimplantation Genetic Testing Major Product Offerings
7.20.4 Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales and Revenue in Global (2018-2023)
7.20.5 Unimed Biotech Key News & Latest Developments
8 Global Non-invasive Preimplantation Genetic Testing Production Capacity, Analysis
8.1 Global Non-invasive Preimplantation Genetic Testing Production Capacity, 2018-2029
8.2 Non-invasive Preimplantation Genetic Testing Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-invasive Preimplantation Genetic Testing Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-invasive Preimplantation Genetic Testing Supply Chain Analysis
10.1 Non-invasive Preimplantation Genetic Testing Industry Value Chain
10.2 Non-invasive Preimplantation Genetic Testing Upstream Market
10.3 Non-invasive Preimplantation Genetic Testing Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-invasive Preimplantation Genetic Testing Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Non-invasive Preimplantation Genetic Testing in Global Market
Table 2. Top Non-invasive Preimplantation Genetic Testing Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Non-invasive Preimplantation Genetic Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Non-invasive Preimplantation Genetic Testing Revenue Share by Companies, 2018-2023
Table 5. Global Non-invasive Preimplantation Genetic Testing Sales by Companies, (K Units), 2018-2023
Table 6. Global Non-invasive Preimplantation Genetic Testing Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Non-invasive Preimplantation Genetic Testing Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Non-invasive Preimplantation Genetic Testing Product Type
Table 9. List of Global Tier 1 Non-invasive Preimplantation Genetic Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-invasive Preimplantation Genetic Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Non-invasive Preimplantation Genetic Testing Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Non-invasive Preimplantation Genetic Testing Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Non-invasive Preimplantation Genetic Testing Sales (K Units), 2018-2023
Table 15. By Type - Global Non-invasive Preimplantation Genetic Testing Sales (K Units), 2024-2029
Table 16. By Application – Global Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Non-invasive Preimplantation Genetic Testing Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Non-invasive Preimplantation Genetic Testing Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Non-invasive Preimplantation Genetic Testing Sales (K Units), 2018-2023
Table 20. By Application - Global Non-invasive Preimplantation Genetic Testing Sales (K Units), 2024-2029
Table 21. By Region – Global Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Non-invasive Preimplantation Genetic Testing Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Non-invasive Preimplantation Genetic Testing Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Non-invasive Preimplantation Genetic Testing Sales (K Units), 2018-2023
Table 25. By Region - Global Non-invasive Preimplantation Genetic Testing Sales (K Units), 2024-2029
Table 26. By Country - North America Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Non-invasive Preimplantation Genetic Testing Sales, (K Units), 2018-2023
Table 29. By Country - North America Non-invasive Preimplantation Genetic Testing Sales, (K Units), 2024-2029
Table 30. By Country - Europe Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Non-invasive Preimplantation Genetic Testing Sales, (K Units), 2018-2023
Table 33. By Country - Europe Non-invasive Preimplantation Genetic Testing Sales, (K Units), 2024-2029
Table 34. By Region - Asia Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Non-invasive Preimplantation Genetic Testing Sales, (K Units), 2018-2023
Table 37. By Region - Asia Non-invasive Preimplantation Genetic Testing Sales, (K Units), 2024-2029
Table 38. By Country - South America Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Non-invasive Preimplantation Genetic Testing Sales, (K Units), 2018-2023
Table 41. By Country - South America Non-invasive Preimplantation Genetic Testing Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales, (K Units), 2024-2029
Table 46. Illumina Company Summary
Table 47. Illumina Non-invasive Preimplantation Genetic Testing Product Offerings
Table 48. Illumina Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Illumina Key News & Latest Developments
Table 50. Thermo Fisher Scientific Company Summary
Table 51. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Product Offerings
Table 52. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Thermo Fisher Scientific Key News & Latest Developments
Table 54. Agilent Company Summary
Table 55. Agilent Non-invasive Preimplantation Genetic Testing Product Offerings
Table 56. Agilent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Agilent Key News & Latest Developments
Table 58. Revvity Company Summary
Table 59. Revvity Non-invasive Preimplantation Genetic Testing Product Offerings
Table 60. Revvity Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Revvity Key News & Latest Developments
Table 62. The Cooper Companies Company Summary
Table 63. The Cooper Companies Non-invasive Preimplantation Genetic Testing Product Offerings
Table 64. The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. The Cooper Companies Key News & Latest Developments
Table 66. Abbott Company Summary
Table 67. Abbott Non-invasive Preimplantation Genetic Testing Product Offerings
Table 68. Abbott Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Abbott Key News & Latest Developments
Table 70. TAKARA Company Summary
Table 71. TAKARA Non-invasive Preimplantation Genetic Testing Product Offerings
Table 72. TAKARA Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. TAKARA Key News & Latest Developments
Table 74. QIAGEN Company Summary
Table 75. QIAGEN Non-invasive Preimplantation Genetic Testing Product Offerings
Table 76. QIAGEN Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. QIAGEN Key News & Latest Developments
Table 78. Vitrolife Company Summary
Table 79. Vitrolife Non-invasive Preimplantation Genetic Testing Product Offerings
Table 80. Vitrolife Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Vitrolife Key News & Latest Developments
Table 82. Oxford Nanopore Technologies Company Summary
Table 83. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Product Offerings
Table 84. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Oxford Nanopore Technologies Key News & Latest Developments
Table 86. Yikon Genomics Company Summary
Table 87. Yikon Genomics Non-invasive Preimplantation Genetic Testing Product Offerings
Table 88. Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Yikon Genomics Key News & Latest Developments
Table 90. Shiva Scientific Company Summary
Table 91. Shiva Scientific Non-invasive Preimplantation Genetic Testing Product Offerings
Table 92. Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Shiva Scientific Key News & Latest Developments
Table 94. Medicover Genetics Company Summary
Table 95. Medicover Genetics Non-invasive Preimplantation Genetic Testing Product Offerings
Table 96. Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Medicover Genetics Key News & Latest Developments
Table 98. MedGenome Company Summary
Table 99. MedGenome Non-invasive Preimplantation Genetic Testing Product Offerings
Table 100. MedGenome Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. MedGenome Key News & Latest Developments
Table 102. Fulgent Company Summary
Table 103. Fulgent Non-invasive Preimplantation Genetic Testing Product Offerings
Table 104. Fulgent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Fulgent Key News & Latest Developments
Table 106. INVICTA GENETICS Company Summary
Table 107. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Product Offerings
Table 108. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. INVICTA GENETICS Key News & Latest Developments
Table 110. Genea Fertility Company Summary
Table 111. Genea Fertility Non-invasive Preimplantation Genetic Testing Product Offerings
Table 112. Genea Fertility Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Genea Fertility Key News & Latest Developments
Table 114. Bioarray Company Summary
Table 115. Bioarray Non-invasive Preimplantation Genetic Testing Product Offerings
Table 116. Bioarray Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Bioarray Key News & Latest Developments
Table 118. GeneMind Biosciences Company Summary
Table 119. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Product Offerings
Table 120. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. GeneMind Biosciences Key News & Latest Developments
Table 122. Unimed Biotech Company Summary
Table 123. Unimed Biotech Non-invasive Preimplantation Genetic Testing Product Offerings
Table 124. Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. Unimed Biotech Key News & Latest Developments
Table 126. Non-invasive Preimplantation Genetic Testing Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global Non-invasive Preimplantation Genetic Testing Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Non-invasive Preimplantation Genetic Testing Production by Region, 2018-2023 (K Units)
Table 129. Global Non-invasive Preimplantation Genetic Testing Production by Region, 2024-2029 (K Units)
Table 130. Non-invasive Preimplantation Genetic Testing Market Opportunities & Trends in Global Market
Table 131. Non-invasive Preimplantation Genetic Testing Market Drivers in Global Market
Table 132. Non-invasive Preimplantation Genetic Testing Market Restraints in Global Market
Table 133. Non-invasive Preimplantation Genetic Testing Raw Materials
Table 134. Non-invasive Preimplantation Genetic Testing Raw Materials Suppliers in Global Market
Table 135. Typical Non-invasive Preimplantation Genetic Testing Downstream
Table 136. Non-invasive Preimplantation Genetic Testing Downstream Clients in Global Market
Table 137. Non-invasive Preimplantation Genetic Testing Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Non-invasive Preimplantation Genetic Testing Segment by Type in 2022
Figure 2. Non-invasive Preimplantation Genetic Testing Segment by Application in 2022
Figure 3. Global Non-invasive Preimplantation Genetic Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-invasive Preimplantation Genetic Testing Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Non-invasive Preimplantation Genetic Testing Revenue, 2018-2029 (US$, Mn)
Figure 7. Non-invasive Preimplantation Genetic Testing Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Non-invasive Preimplantation Genetic Testing Revenue in 2022
Figure 9. By Type - Global Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
Figure 11. By Type - Global Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
Figure 12. By Type - Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
Figure 15. By Application - Global Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
Figure 16. By Application - Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
Figure 20. By Region - Global Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
Figure 21. By Country - North America Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
Figure 22. By Country - North America Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
Figure 23. US Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
Figure 28. Germany Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 29. France Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
Figure 37. China Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 41. India Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
Figure 43. By Country - South America Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
Figure 44. Brazil Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Market Share, 2018-2029
Figure 48. Turkey Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Non-invasive Preimplantation Genetic Testing Revenue, (US$, Mn), 2018-2029
Figure 52. Global Non-invasive Preimplantation Genetic Testing Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Non-invasive Preimplantation Genetic Testing by Region, 2022 VS 2029
Figure 54. Non-invasive Preimplantation Genetic Testing Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 単因子&単一遺伝子欠陥キット着床前遺伝子検査のグローバル市場展望 2023年-2029年：ハイスループットシーケンシング、その他
  • ヘリコバクター・ピロリ菌非侵襲的検査のグローバル市場展望 2023年-2029年：血清学的検査、尿素呼気検査（UBT）、便抗原検査（SAT）
  • 侵襲的SEEG深部電極のグローバル市場展望 2023年-2029年：接点：8以下、8-12、12以上
  • 侵襲性真菌感染症診断のグローバル市場展望 2023年-2029年：GM試験、(1,3)-β-D-G試験
  • 非電子低侵襲グルコースセンシング技術のグローバル市場展望 2023年-2029年：臨床用非電子低侵襲グルコースセンシング技術、臨床血糖計用非電子低侵襲グルコースセンシング技術
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC16262 )"非侵襲的着床前遺伝子検査のグローバル市場展望 2023年-2029年：着床前遺伝子スクリーニング、着床前遺伝子診断" (英文：Non-invasive Preimplantation Genetic Testing Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。